Daily Health Headlines

Blood Test Might Someday Predict Your Stroke Risk

👤by HealthDay 0 comments 🕔Thursday, August 25th, 2016

WEDNESDAY, Aug. 24, 2016 (HealthDay News) -- In the doctor's office of the future, a simple blood test might gauge a patient's odds of suffering a stroke someday, new research suggests.

A team of Canadian researchers measured levels of blood-borne chemical signals, or "biomarkers," in the blood of more than 3,200 people.

The patients averaged 61 years of age and were tracked for an average of nine years. During that time, 98 of them did suffer a stroke.

Elevated levels of four of the biomarkers were linked with increased stroke risk, the team reported in the Aug. 24 online edition of the journal Neurology.

High blood levels of the chemical homocysteine indicated a 32 percent higher risk compared to people with the lowest levels, the researchers found. And high levels of three other biomarkers -- vascular endothelial growth factor, C-reactive protein, and tumor necrosis factor receptor 2 -- also indicated a similar heightening of stroke risk, the investigators said.

"Identifying people who are at risk for stroke can help us determine who would benefit most from existing or new therapies to prevent stroke," study lead author Dr. Ashkan Shoamanesh, of McMaster University in Ontario, said in a journal news release.

Two cardiologists agreed the idea has merit.

"This study is important because it may help to identify patients at high risk for future stroke and implement preventive measures beforehand, and not in reaction to a stroke," said Dr. Akira Todo, who directs the Stroke Program at Northern Westchester Hospital in Mount Kisco, N.Y.

Dr. Andrew Rogove is medical director of stroke at Southside Hospital in Bay Shore, N.Y. He called the work "both interesting and important."

"Stroke affects nearly 800,000 Americans each year, and it is the fifth leading cause of death and a leading cause of disability in the United States," he noted.

"If there were more biomarkers available to identify people at risk of stroke, this would invariably lead to prevention therapies, to lower the number of stroke victims," Rogove said.

Still, Shoamanesh cautioned that this research is still in its early days, and more work on the blood test is needed.

"Our study does not provide evidence that these markers are validated well enough to be implemented in clinical practice," he said.

-- Robert Preidt

Article Credits / Source


HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Akira Todo, M.D., director, stroke program, Northern Westchester Hospital, Mount Kisco, N.Y.; Andrew Rogove, M.D., Ph.D., medical director of stroke, Southside Hospital, Bay Shore, N.Y.; Neurology, news release, Aug. 24, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Neurology Articles

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- Some children born to mothers with rheumatoid arthritis may have higher-than-average odds of developing epilepsy, a new study suggests. Children born to mothers with rheumatoid arthritis were ...

Brain Implant Lets 'Locked-In' ALS Patient Communicate

Brain Implant Lets 'Locked-In' ALS Patient Communicate0

MONDAY, Nov. 14, 2016 (HealthDay News) -- A high-tech implant has enabled a paralyzed woman with late-stage ALS (amyotrophic lateral sclerosis) to communicate through brain signaling, researchers say. The degenerative disease robbed Hanneke De ...

Blood Test May Someday Diagnose Concussion

Blood Test May Someday Diagnose Concussion0

FRIDAY, Nov. 11, 2016 (HealthDay News) -- A simple blood test may one day diagnose concussions with more than 90 percent certainty, a small Canadian study suggests. This new test is unique, the authors said, because it looks for more than 100 ...

gabapentin (Neurontin, Gralise, Horizant, Fanatrex FusePag)

gabapentin (Neurontin, Gralise, Horizant, Fanatrex FusePag)0

home / neurology center / neurology a-z list / gabapentin index / gabapentin (neurontin, gralise, horizant, fanatrex fusepag) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, ...

MS Symptoms May Develop Earlier in Darker, Cooler Climes

MS Symptoms May Develop Earlier in Darker, Cooler Climes0

THURSDAY, Nov. 3, 2016 (HealthDay News) -- The farther from the Equator someone with multiple sclerosis lives, the earlier symptoms begin, a new study finds. MS is a progressive disease affecting the central nervous system. Although symptoms ...

View More Neurology Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!